Simulations Plus, Inc. SLP reported first-quarter fiscal 2026 adjusted earnings of 13 cents per share, lagging the Zacks ...

Simulations Plus Inc. (NASDAQ: SLP) shares climbed on Tuesday after the company reported better-than-expected fourth-quarter 2025 earnings and reaffirmed annual guidance. • SLP is among today’s top ...

Q3 sales of $20.4 million missed the $20.9M consensus; EPS rose to $0.43 from $0.27 last year. FY25 EPS guidance cut to $0.93–$1.06 from $1.07–$1.20; net loss was $67.3 million on a $77.2 million ...

Simulations Plus, Inc. (SLP) reported third-quarter fiscal 2025 adjusted earnings of 45 cents per share, which expanded 66.7% year over year. The figure also surpassed the Zacks Consensus Estimate of ...

Simulations Plus has recently declined after its Q3 2025 report, despite having a healthy revenue growth and adjusted EPS beat. This decline was mostly driven by a non‑cash impairment and lowered ...

Simulations Plus, Inc. (NASDAQ:SLP) is one of the Best Beaten Down Stocks to Buy Now. KeyBanc downgraded the company’s stock to “Sector Weight” from “Overweight” without a price target, as reported by ...

Detailed price information for Simulations Plus Inc (SLP-Q) from The Globe and Mail including charting and trades.

Simulations Plus is a specialized in silico software-and-services platform. They help with model-informed, non-animal drug development. SLP’s services help across discovery, development, and clinical ...